Effect of Evolocumab on Carotid Plaque Composition in Asymptomatic Carotid Artery Stenosis (EVOCAR-1)
Status:
Recruiting
Trial end date:
2023-09-04
Target enrollment:
Participant gender:
Summary
This is a phase IV, randomised, placebo-controlled, double-blind, parallel group study to
determine the effect of Evolocumab treatment on carotid plaque morphology and composition in
asymptomatic patients with >50% carotid artery stenosis.